TY - JOUR
T1 - Liver transplantation for primary biliary cirrhosis
AU - Neuberger, James
PY - 2003/1/1
Y1 - 2003/1/1
N2 - Liver transplantation is now the accepted treatment for patients with end-stage disease or intractable symptoms. The success rate is high. Those grafted for PBC are at greater risk of developing acute and chronic rejection and are less likely to be weaned from immunosuppression. Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years.
AB - Liver transplantation is now the accepted treatment for patients with end-stage disease or intractable symptoms. The success rate is high. Those grafted for PBC are at greater risk of developing acute and chronic rejection and are less likely to be weaned from immunosuppression. Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years.
UR - http://www.scopus.com/inward/record.url?scp=0041880706&partnerID=8YFLogxK
U2 - 10.1016/S1568-9972(02)00103-9
DO - 10.1016/S1568-9972(02)00103-9
M3 - Review article
C2 - 12848968
VL - 2
SP - 1
EP - 7
JO - Autoimmunity Reviews
JF - Autoimmunity Reviews
IS - 1
ER -